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Specialist paediatric palliative care services: what are the 
benefits? 
 
Abstract 
Background: The number of children and young people (CYP) living with life-limiting and life-
threatening conditions is rising. Paediatric palliative care is a relatively new aspect of healthcare, the 
delivery of which is variable, with a wide range of healthcare and voluntary sector providers 
involved. Policy recommendations are for specialist paediatric palliative care (SPPC) services to be 
supported by a physician with specialist training.  
Aim:  To examine the research evidence regarding the distinct benefits of SPPC services, with 
“Specialist Paediatric Palliative Care” defined as palliative care services supported by a specialist 
physician.   
Method: Systematic review of studies of SPPC services published in English from 1980-2016. 
Keyword searches were carried out in medical databases (Cochrane, PubMed, EMBASE, CINAHL, and 
AMED), and a narrative synthesis.  
Results: Eight studies were identified, most of which were retrospective surveys undertaken within 
single institutions; three were surveys of bereaved parents and three were medical notes reviews.  
Together they represented a heterogeneous body of low-level evidence. Cross-cutting themes 
suggest that SPPC services improve quality of life and symptom control, and can impact positively on 
place of care and family support.   
Conclusion: Current evidence indicates that SPPC services contribute beneficially to the care and 
experience of CYP and their families, but is limited in terms of quantity, methodological rigour and 
generalisability. Further research is necessary given the significant workforce and resource 
implications associated with policy recommendations about the future provision of SPPC, and to 
address the need for evidence to inform the design and delivery of SPPC services.  
  
 
Patient and Public Involvement 
The study was designed in close consultation with patient and public involvement (PPI) groups at 
Acorns Children’s Hospice and Birmingham Children’s Hospital.  LS is 15 years old and a member of 
Acorns Sibling Council who has provided PPI support to this systematic review. She has advised on 
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What is already known? 
 The numbers of children and young people (CYP) living with life-limiting and life-threatening 
conditions is rising with continuing advances in clinical medicine.  
 There are international recommendations and standards for Specialist Paediatric Palliative 
Care (SPPC) services but this is a relatively new subspeciality and is inconsistently available.  
 The more universal adoption of recommendations and standards requires significant 
investment of resource, which is difficult to achieve. 
 
What this study adds 
 This is the first systematic review of research related to the evaluation of SPPC.  
 The review identifies a summary of the evidence that suggests that SPPC provides benefit to 
CYP and families. 
 Key themes have been identified to inform future service development and research in 
paediatric palliative care.  
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Introduction 
With advances in medical treatments and the use of medical technology, a growing number of 
children and young people (CYP) live with life-limiting (LLCs) and life-threatening conditions (LTCs) (1, 
2). This includes CYP who live with conditions where curative treatment is feasible but can fail, while 
for others, there is no known cure (3).  Ensuring sustainable healthcare services that can effectively 
meet the needs of these CYP and those of their families presents a significant challenge.  
Palliative care for CYP has been defined as “an active and total approach to care, from the point of 
diagnosis or recognition, embracing physical, emotional, social and spiritual elements through to 
death and beyond. It focuses on enhancement of quality of life for the CYP and support for the 
family and includes the management of distressing symptoms, provision of short breaks and care 
through death and bereavement (3).” Globally, it is estimated that seven million CYP (aged 0-19) 
could benefit from palliative care services (4), with at least 49,000 in the UK (5).  However most 
countries have no paediatric palliative care services, including hospices (4).  Where paediatric 
palliative care services have developed this has been largely as a result of the determination of 
motivated individuals and charitable funders (6, 7). The type and availability of services varies 
geographically due to the wide range of healthcare and voluntary sector providers involved (4).  
Specialist Paediatric Palliative Care (SPPC) services are defined in UK and European standards as 
those supported by a physician with specialty training (a consultant) in paediatric palliative medicine 
(1, 8-10). However, SPPC is yet to become an established medical sub-specialty, and few countries 
have doctors trained to this level (4). As a result, there is a tension between this standard of care 
and the many existing services which specialise in the provision of paediatric palliative care but lack 
the support of specialty trained physicians. 
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Objective 
The objective of this systematic review is to contribute to the debate regarding the design of 
paediatric palliative care services by specifically examining SPPC, defined as a palliative care service 
supported by a physician with specialty training in paediatric palliative medicine, and asking “what 
are the distinct benefits of these SPPC services to CYP and their families?” The review also provides 
an opportunity to identify evidence gaps for further research.  
 
Design 
The Centre for Reviews and Dissemination (CRD) guidance for systematic reviews in healthcare, and 
the Cochrane Collaboration’s handbook for systematic reviews of interventions informed the 
review’s methodology (11, 12). The structure and content was informed by the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines (13). A protocol has been 
registered and published on the PROSPERO database (ref no: CRD42016050677). 
Search strategy 
Information sources: The following electronic databases were searched from September 2015 to 
January 2016 with the last search on 07.1.2016.  
 Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews 
● PubMed (1980 onwards)  
● EMBASE (1980 onwards) 
● CINAHL (1981 onwards) 
● AMED (1985 onwards) 
After initial broad scoping searches, the search terms outlined in table 1 were used to perform a 
focused systematic search. The population search was carried out first, followed by the intervention 
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search. The search was carried out with the advice of the University of Warwick specialist librarian. 
Hand searching of references, “cited by” and PubMed related articles link searches were also carried 
out.  
Table 1: Search Strategy 
Population Pediatr* / Paediatr*  
AND (Infant OR Child* OR Adolescen*) 
Intervention Palliat*  
Special* 
End-of-life 
Hospice 
Terminal care 
Consultant 
Physician 
Delivery of healthcare 
Service 
 
 
Inclusion / Exclusion Criteria 
Inclusion and exclusion criteria are outlined in Table 2.   
Table 2: Inclusion and Exclusion Criteria 
PICOS Dimension Inclusion Exclusion  
Population Children and young people aged from 
0-18 years (inclusive) 
Studies concerning neonatal palliative 
care  
Studies concerning specifically young 
people making the transition to adult 
services  
Adult studies 
Intervention “Specialist Paediatric Palliative Care” 
defined as a palliative care service 
Paediatric palliative care services that 
did not meet the specialist 
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supported by a physician with 
speciality training in paediatric 
palliative medicine, as per current 
recommendations and service 
specifications.  
  
specification, including hospice services, 
and services supported by 
paediatricians who had not received 
specialty training in paediatric palliative 
medicine (where it was possible to 
establish this). 
Neonatal palliative care services 
Adult palliative care services (who may 
be catering for paediatric patients)  
Any other usual care  
Comparator Usual care or palliative care that was 
provided by other types of service 
 
Outcomes Any formal measure of evaluation 
concerning the acceptability or 
effectiveness of the intervention.  
 
Study design Any evaluative study design Review articles, descriptive or 
theoretical papers that did not present 
original research findings 
 
Publication  Databases were searched from 1980 
onwards.  
Unpublished grey literature 
Non-English language papers  
Articles only available in abstract form 
where no full text is available (the 
authors were contacted)  
Voluntary sector reports 
  
Study selection: Duplicate articles were removed. Titles and abstracts were screened, followed by 
examination of the full text. Articles were assessed for inclusion independently by three reviewers 
(SM, KB and AM).   
Data management: Two reviewers extracted relevant data to an Excel spreadsheet (AM and KB), 
which was independently checked for accuracy and detail by SM. The team discussed any 
disagreements. 
Data synthesis: The included studies were compared and contrasted using a data extraction table. 
There were no comparable statistics and therefore a systematic narrative synthesis (14) was 
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undertaken, identifying cross-cutting themes from each study. The narrative was reviewed at 
intervals by LS, our PPI co-author, with feedback provided on relevance to family experience, and by 
JD for intellectual content.   
Results  
Study selection: 770 relevant articles were identified. 755 were excluded after title and abstract 
screening and the removal of duplicates, leaving 15 articles. Three of these were conference 
abstracts of ongoing studies which were not available as full text articles or as unpublished studies 
from the authors, and were therefore excluded. After applying the inclusion and exclusion criteria to 
the remaining 12 articles, four were excluded because they did not concern SPPC services with 
specialist medical support, leaving eight articles. This process is shown in Figure 1. Study 
characteristics are summarised in Table 3.  
Study location: Included studies were from the USA (15-18), the UK (19), Germany (20), Australia 
(21), and Canada (22).   
Study quality: The studies represented a heterogeneous body of evidence (13); seven were 
retrospective studies (15-19, 21, 22); three were surveys of bereaved parents (15, 17, 22), one was 
an epidemiological study (19) and three were medical notes reviews (16, 18, 21), one of which 
included an economic analysis (18). There was one prospective longitudinal survey (20). There were 
no randomized-controlled trials or systematic reviews. All had clear aims and used appropriate 
methodology, and approached the ethical issues. All acknowledged the limitations in their study 
design and recruitment strategies, and data was collected in a way that would address the research 
aims. All gave clear descriptions of their data analysis, results and findings (23).  
All had been published since 2012 and were carried out within single institutions or services. The 
largest study in terms of patient numbers was an epidemiological study, which looked at data 
regarding 2508 CYP but was limited by missing data items (19). The notes review studies examined 
the care of a total of 611 children and young people (16, 18, 21). Three studies concerned only CYP 
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with cancer (15, 19, 22).  The other five studies concerned services for CYP with non-malignant 
conditions as well as those with cancer (16-18, 20, 21).  
Four studies made use of questionnaires with caregivers (15, 17, 20, 22); three were surveys of 
bereaved parents (15, 17, 22). The total number of bereaved parents included in these studies was 
200. Time since bereavement ranged from seven months to over four years (15, 17, 22). Response 
rates for postal surveys of a total number of bereaved parents in a time period were 65/192 (37%) 
(17) and 60/166 (36%) (15). A response rate of 75/140 (75%) was achieved where eligibility criteria 
were applied (22). The highest response rate for a questionnaire survey was 93% (40/43), with the 
questionnaire administered face to face with family members at the time they were receiving care 
from the SPPC service (20). This study also attempted the assessment of children by self-report but 
due to young age and clinical condition this was possible with only three CYP (20).  
Key themes 
Four key themes about how SPPC services can impact on CYP and their families were identified. 
These related to:  
1. Quality of life 
2. Symptom control 
3. Place of care 
4. Family support 
 
Quality of Life 
The studies provide evidence that SPPC services contribute to improving the quality of life of CYP 
and family through emotional support, care planning and help with medical decision making (16, 17, 
20-21), as well as through the management of distressing physical symptoms (17, 21). Improved 
satisfaction with care was reported once SPPC services were involved (16, 20). One study reported 
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that CYP who were in contact with a SPPC ‘had more fun and [were] more likely to have an 
experience which added meaning to their life’ (15) than those who were not. 
Symptom control 
Pain and symptom management was described as one of the main reasons for referral to SPPC (21). 
Improvements in children’s symptom control with the involvement of the SPPC team were reported 
by parents retrospectively (15, 20). With the involvement of SPPC services, more care including 
symptom management was delivered in the home environment (15), alongside other support for 
caregivers and practical support (20).  
Place of Care  
Three studies provided evidence to suggest that referral to SPPC is associated with fewer admissions 
to hospital (19, 20) or a reduced length of stay (18).  The involvement of SPPC services was 
associated with care planning discussions and considering a preferred location of death (16, 22). 
More CYP died at home with SPPC involvement than not (15, 20). Differences in terms of both 
diagnosis and geographical location of the family home contributed to the location of death. In one 
study, CYP with a cancer diagnosis were more likely to die at home if they lived in a rural location; 
CYP with non-malignant disease were more likely to die in a tertiary hospital (21).  However, there 
was evidence that “goals of care” discussions tended to occur relatively late, with the median time 
before death that this discussion took place being 16 days (16).   
Family experience 
There were several areas in which SPPC intervention was reported as contributing to an 
improvement in family members’ quality of life (20, 22). Access to services 24 hours a day, 7 days per 
week was valued (20). Perception of psychological support and support for carrying out “day-to-day 
activities” increased, and there was a decrease in anxiety and depression amongst parents (20). 
SPPC teams provided support with medical decision making (16, 17), including discussions about 
resuscitation (16, 22), help with communication between family members, including with their child, 
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and with other healthcare teams (17, 20, 22). The SPPC team played an important role in educating 
parents about both the process of death and aspects of the medical system (17).  
Low referral rates to SPPC services were described (19) and the average length of time that a child 
was under the care of SPPC varied from 20 days to over one year (16, 18, 21, 22). Feedback from 
families included a desire that SPPC was involved earlier on in the course of a child’s illness (17).  
Discussion 
This review set out to investigate the current evidence regarding the distinct benefits to CYP and 
their families of care provided by SPPC, defined as a palliative care service supported by a physician 
with specialist training.  
A small number of studies met the inclusion criteria, all of which had been published within the last 
five years. All of these were single centre studies with relatively small patient numbers, and rank low 
in the hierarchy of evidence due to their methodological limitations (12). This is a well-recognised 
problem in palliative care research, due to clinical and ethical challenges, and brings into question 
the value of systematic reviews in this subject area (24). Specific methodological challenges exist 
around gatekeeping of participants by clinicians (25), which was described as a barrier to 
recruitment in one study (22). In surveys, families were found to be unreachable by phone or post, 
did not respond, or were ineligible to participate due to language barriers (15, 17, 20, 22). Where 
families did respond, they are likely to have been particularly motivated to participate, and therefore 
the survey findings may not be generalisable to a more diverse population of families. One study 
tried to collect the views of CYP, but found this was not possible (20).  
Benefits of SPPC 
Despite the limited quality of the evidence, there are cross-cutting themes from the eight studies 
suggesting that SPPC may enable improved quality of life for CYP and parents, improved symptom 
control, has an impact on the place of care and an increased likelihood that a preferred place of 
death is achieved (16, 17, 20-22).  
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Service delivery  
The review is timely as the specialty of paediatric palliative medicine further develops, with  
international standards, specifications and recommendations (8-10, 26). Systematic consideration of 
the available evidence to support the development of services and policy is necessary, particularly as 
the number of CYP with LLCs and LTCs rises.  
There is ongoing emphasis on place of death as an outcome measure in palliative care, despite a 
limited evidence base to support this (27). “Choice” in end-of-life care is frequently highlighted in 
policy (28), and families desire the option of care being provided at home (29). This review suggests 
an association between referral to a SPPC team and opportunity to firstly express preferences for 
“goals of care” and location of death, and then achieve it (15, 16, 22), although there was some 
evidence that this occurred relatively late in the course of illness (16).  Key factors that enable these 
discussions have been described as continuous relationships, time for open, honest conversations, 
and the provision of symptom control (15, 20, 29, 30). 
Although adequate control of symptoms was not always perceived by parents (15, 17), there was 
evidence to suggest that more effective symptom control could be delivered in the home 
environment with the involvement of an SPPC team (15). Further research into symptom 
management in CYP including use of medications and routes of administration, and how this can be 
delivered in both community and inpatient care settings, is an important focus for SPPC.  
SPPC service design 
What cannot be ascertained from the available evidence is which elements of SPPC services are 
associated with the benefits described, the mechanisms by which these benefits occur or the impact 
of the presence of a specialty-trained physician. This review looked specifically at services with a 
specialty-trained physician, and excluded studies of any other model of care. However, nurse-led 
paediatric palliative care services and children’s hospice services have also been shown to benefit 
CYP and their families particularly in terms of place of care (31-34), co-ordination of care (35) and 
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family support (36). Research to compare more clearly the different types of services, and how they 
can effectively work together, would be valuable. Further research to investigate the most effective 
services for children with differing life-limiting conditions would also be of value given the wide 
variation in disease trajectories, family need and outcomes (3).  
The benefits of a specialist physician in a service have been broadly described as advanced clinical 
expertise, and academic, educational and strategic leadership (37), all of which are important in 
SPPC as the specialty develops. Securing funding to develop both specialty training and new 
consultant posts presents a major challenge and will require clear business cases. Future innovation 
and development of the SPPC workforce, and the implementation of new policies, including NICE 
guidance (26), should be accompanied by robust plans for evaluation.     
This review identified only one study which made reference to the value of parental input into the 
development of SPPC services (17). Co-design of services with CYP and families (28, 38), and work to 
address possible reasons for low referral rates to SPPC, such as negative perceptions of palliative 
care amongst families (39) and healthcare professionals (40, 41) would be highly relevant. 
 
Conclusion 
Future service development recommendations should address the need for accessible and 
sustainable SPPC services for all CYP who need them.  However, as this review demonstrates there is 
limited evidence to inform policy guidance within the overall provision of paediatric palliative care. 
In the context of a growing number of CYP and families who could benefit from SPPC, there is a need 
for further research, innovation and debate. Robust evaluation of services, care models and 
professional roles, as well as research to understand the mechanisms by which benefits are 
delivered to CYP and families, are necessary. These are key considerations for those who are leading 
the development of SPPC, and for service commissioners.   
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Table 3: Study Characteristics: 
Study Design & Research 
Questions 
Participants  Intervention Findings  
M. J. Sheetz et al (2012) 
(17) 
 
What are parents’ perceptions 
about whether a SPPC programme 
was providing key elements of 
paediatric palliative care? 
Are parents satisfied with the 
service?  
Questionnaire survey of parents 
whose children were receiving care 
from a specific SPPC programme.  
Salt Lake City, USA 
 
Parents of 65 children who had died 
while under the care of the 
programme. 
CYP with a range of LLCs and LTCs, 
including cancer and complex chronic 
conditions, most frequently genetic / 
congenital, neuromuscular and 
cardiovascular conditions.  
SPPC programme: MDT including 
pediatrician and nurse 
practitioner board-certified in 
PPM, nurse manager, social 
worker, chaplain. 
Hospital-based inpatient 
consultation service and home 
consultation service after 
discharge. Age range prenatal-36 
years.  
 
65/192 responded (37%). 37% (22) of children had died at home, 53% (32) at the 
hospital, and 8% (5) at another hospital, 2% (1) in a long term care facility. 21 were also 
receiving hospice services at the time of death.  
95% agreed or strongly agreed that the SPPC team helped them make decisions about 
their child’s care, 5% disagreed. 76% felt the team had helped them set goals for care 
(others unsure or disagreed), 78% agreed that those goals of care were subsequently 
met. 13% unsure, 10% disagreed. 
95% felt supported in their choices for their child’s care. Also 78% felt that physical 
pain / distressing symptoms were controlled at the end of life, 22% unsure or 
disagreed. 71% felt symptoms other than pain were controlled adequately. High levels 
of parent satisfaction with SPPC. SPPC had an important role in education: decision 
making, the process of death and aspects of the medical system. Feedback included a 
desire that the team were involved sooner. 
L. K. Fraser et al (2013)  
(19) 
 
 
What is the impact of SPPCS on the 
number of hospital admissions in 
children before their death with 
cancer?  
Retrospective cohort study of 
epidemiological data. Differences in 
hospital admission patterns were 
assessed using negative binomial 
regression  
Yorkshire, UK 
2508 patients aged 0-19 years with 
cancer from 1990-2009, who were in 
the catchment area for the SPPCS.  
. 
SPPC based at a children’s (aged 
up to 35 years) hospice with a full 
time consultant from 2004. 24 
hour on call medical service, and 
a home visiting service.  
27.7% of those who had died were referred to SPPC (less than a third). 182 had died 
and had been referred, 475 had not been referred before they died. No significant 
difference in terms of demographics. Most commonly referred were those with CNS 
tumours.  
Referral to SPPC was associated with a significantly lower rate of planned hospital 
admissions (IRR=0.60, 95% CI 0.43-0.85). There was no significant difference in 
emergency (which comprised 97% of admissions) or total hospital admission rates. 
Children with CNS tumours had significantly less hospital admissions compared to 
those with leukaemia (may be due to the nature of treatment).  
 
Groh et al (2013)  
(20) 
 
Does the involvement of a SPPC 
team (home care) address the 
needs of patients and their families 
and thus lead to an increase in 
acceptance and effectiveness of 
SPPC? 
Prospective non-randomised study 
with two validated questionnaires; 
the first during the first week pf 
All primary caregivers of severely ill 
children receiving SPPC via the PPHC 
team for the first time between Apr 
2011 and June 2012.  
40 families. 18 CYP died before study 
ended. 16 of them at home. Wide 
range of diagnoses including cancer 
and complex chronic conditions 
Multiprofessional SPPC team 
consisting of three pediatricians, 
two nurses, a social worker and a 
chaplain, all with special training 
in palliative care. 24/7 on-call.  
SPPC was assoc with improved satisfaction with care and quality of care. Significant 
improvement in children’s symptom control and quality of life as perceived by parents. 
Parents own QoL and burden relief significantly increased and psychological distress 
and burden decreased. SPPC led to reduced rates of hospitalization and improved 
caregiver satisfaction with care received including psychological support and support 
of activities of daily living. 
Caregiver’s felt more informed on disease situation and progression, better taken care 
of, improved communication with child. Psychosocial support was identified as the 
19 
paediatric palliative home care 
(SPPC) service involvement, and the 
second a few days - six months 
later depending on clinical 
condition. Face to face by a trained 
psychologist.  
Bavaria, Germany 
 
 
 
most helpful aspect of care. 24/7 on-call service and time for detailed conversations 
highly valued, as were support with practicalities e.g. ACP, equipment. 
L Niswander et al.  
2014 
(16) 
What SPPC are CYP receiving at 
home, and how is their end-of-life 
experience perceived by parents 
and medical personnel.  
Retrospective cohort review of 
medical notes of children who died 
from Dec 2004 – May 2008.  
New York, USA 
36 children who died with a wide 
range of diagnoses, including cancer, 
enrolled in the program for a median 
1.1 years before they died.  
 
A team consisting of pediatric 
nurses, pediatric nurse 
practitioners, a pediatrician 
board-certified in hospice and 
palliative medicine, child life 
specialists, social workers, 
chaplain, and expressive 
therapists. 
 
There was a median of 3 hospitalizations (inc planned), 2 emergency room visits in the 
last 6m of life. Median of 24 home visits (1-121), home visit frequency varied.  
Symptom control was important, as were “goals of care” discussions, which happened 
a median of 16 days before death (0-116). 25 had home DNACPR. 15 CYP were aware 
of impending death (recorded) – tended to be older CYP. 16 children died at home, 20 
died in hospital. 16 had recorded PPD. 
Conclusion was that children who die of complex chronic conditions spend most of 
their last 6 months at home, community SPPC contributes substantially to their care 
and comfort.  
Postier et al. 
2014 
(18) 
What is the healthcare utilization 
by children prior to enrollment in 
SPPC compared to the period after 
enrollment? 
Retrospective cohort study of 
electronic medical records, and 
economic analysis.  
Minneapolis, USA 
425 Children with a range of 
diagnoses aged 1-21 under the care 
of SPPC for at least one day between 
2000-2010 
24/7 access and care co-
ordination through home visits 
by nurses, social workers, child 
life specialists, chaplains, music / 
massage therapists, physicians 
and volunteers.  
No of hospital admissions didn’t change. Length of stay decreased by two weeks post 
SPPC involvement, with a significant drop in healthcare costs.  
Largest decreases in resource utilization for the non-malignant group – reduced length 
of stay in hospital with SPPC involvement, decrease in hospital charges for those under 
SPPC > 6 months.  
Herbert et al (2014)  
(21) 
What are the characteristics of the 
population care for by the SPPC 
service, what outcomes are the 
SPPC achieving and how has the 
service developed?  
Retrospective cohort review of 
medical notes of children who were 
referred to the service in a 2 year 
period.   
Brisbane, Australia 
150 patients referred over a 24-
month period. Wide range of 
diagnoses.  
 
 
The SPPC developed from the 
existing pediatric oncology 
palliative care service at the RCH, 
and incrementally expanded over 
a period of 3 ½ years, 
commencing with a dedicated 
pediatrician trained in palliative 
care, followed by nursing staff 
and the addition of dedicated 
allied health staff from 2010. 
Offers biannual training days and 
videoconferencing. 24/7 
telephone support.  
Median duration of contact time with the service was 83 days. Non-oncology diagnosis 
was likely to result in longer use of the service (>6m).  41% of children died at home 
and 48% died at hospital. 
Reasons for referral: Pain and symptom management (29%), Advanced care planning 
(25%), Community care planning (21%), End of life care (26%). 
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Friedrichsdorf (2015) 
(15) 
How does end-of-life pain and 
symptom management in children 
with advanced cancer who received 
care exclusively from oncology 
compare with those who received 
concurrent SPPC home care? 
What are the differences between 
the two groups regarding health 
outcomes inc QoL and location of 
death.  
Retrospective cohort survey study 
of bereaved parents whose 
children died of cancer 
Minneapolis, USA 
Final sample of 60 bereaved parents 
of children who died of cancer 
between 2002-08 at a US tertiary 
paediatric institution 
 
. 
PPC nurses, social workers, and 
chaplaincy. A PPC physician 
and/or pediatric oncologist or 
oncology advanced practice 
registered nurse. 24/7 nursing 
on-call for home visits  
No significant difference in prevalence of symptoms between those referred to SPPC 
and those who were not. There was a trend towards greater perceived suffering from 
pain in the group who were not referred to SPPC group. Seizures and nausea/vomiting 
were the most successfully managed in both groups.  
More parents in SPPC group wanted their child to die at home and had opportunity to 
plan this. More children in PPC group did die at home. SPPC children had more fun and 
more likely to have an experience, which added meaning to their life. 
A Kassam et al 
2015 
(22) 
Is referral to SPPC associated with 
improved end-of-life care 
communication for children with 
advanced cancer and their families?  
Questionnaire survey and medical 
record review examining 
differences in end-of-life 
communication for children with 
advanced cancer who were 
referred to a SPPC team 
Toronto, Canada 
75 bereaved parents  
 
 
PACT team Four palliative care 
physicians, three nurses, two 
grief support coordinators and 
one administrative assistant. 
PACT also draws on the special 
knowledge of other professionals 
and volunteers like chaplains, 
social workers, nurses, 
bioethicists, physicians, pain 
experts, volunteers and parents. 
Most frequent communication was DNACPR discussion. 
Least frequent was discussion of death and dying when appropriate, and advice on 
how to talk to child about this 
Univariate analysis showed parents more likely to have the following five 
communication elements if a palliative care team were involved: Discussion of death 
and dying with parents and with the child, guidance on how to talk to their child, 
preparing parents for medical aspects of death and sibling support.  
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